A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and Company Applies for Patent on Chronic Nightly Dosing of Lasmiditan for Migraine Prevention

Regeneron Pharma Submits Patent Application for Treatment of Varicose Veins with PIEZO Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Agonists

Patent Issued for Anti-VEGF protein compositions and methods for producing the same (USPTO 11958894)

TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non–muscle-invasive bladder cancer, respectively

Patent Issued for Pharmaceutical composition (USPTO 11951103)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count